News

11:18 AMYahoo Finance

Merck’s Keytruda Combo cut melanoma recurrence or death risk 42%. What the February 2 report has to Prove

MRK−0.1%MRNA−7.0%

11:15 AMYahoo Finance

What Merck KGaA (MRK) said on its Q3 earnings call

MRK−0.1%

6:45 AMYahoo Finance

Merck to Participate in the Jefferies Global Healthcare Conference in London

MRK−0.1%

1:59 AMYahoo Finance

Merck shares hit over 1-year high as Q3 beats estimates and outlook is raised

MRK−0.1%

9:44 AMYahoo Finance

Global Biotechnology market to reach $5 trillion by 2032, driven by Biopharmaceuticals, gene editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher and more

DHR−1.4%ILMN−1.6%MRK−0.1%

4:16 AMYahoo Finance

Up 42% since January: Why Merck is defeating the patent cliff

MRK−0.1%

3:46 AMInvesting.com

Up 42% since January: Why Merck is defeating the patent cliff

MRK−0.1%

12:13 AMYahoo Finance

Merck (MRK) could be 7% undervalued as MASH trial data lifts Optimism

MRK−0.1%

11:35 PMYahoo Finance

Merck shares rose even as profit fell

MRK−0.1%

12:57 PMYahoo Finance

Merck vs. Gilead Sciences: Which dividend stock Pays you more in 10 years?

MRK−0.1%GILD−1.0%

8:11 AMYahoo Finance

Can you still buy Merck stock today?

MRK−0.1%

3:02 PMSeeking Alpha

Merck MASH asset efinopegdutide meets primary goal in mid-stage trial

MRK−0.1%

1:05 PMYahoo Finance

Merck announces positive results from Phase 2b trial of efinopegdutide in Adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Stage 2-3 fibrosis

MRK−0.1%

10:40 AMYahoo Finance

INVA or MRK: Which is the better value stock right now?

MRK−0.1%

7:48 AMYahoo Finance

MRK's 2027 outlook challenging, long-term Prospects Promising

MRK−0.1%

6:07 AMYahoo Finance

Merck (MRK) Starts ENHANCE 3 COPD trial as Cancer Drug Review nears

MRK−0.1%

5:07 AMYahoo Finance

Is Merck (MRK) undervalued after its Cancer Trial wins?

MRK−0.1%

4:20 AMYahoo Finance

Zacks investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck

MRNA−7.0%ABBV−0.2%LLY−0.5%+1

10:34 AMYahoo Finance

Merck & Co., Inc. (MRK): A top 10 Healthcare stock to buy following the 2026 Democratic Midterm Sweep

MRK−0.1%